| http://www.w3.org/ns/prov#value | - ving fentanyl transdermal system and any CYP3A4 inhibitor and reduce the dosage of fentanyl transdermal system if warranted [see Clinical Pharmacology (12.3)]. 7.2 Central Nervous System Depressants The concomitant use of fentanyl transdermal system with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines)
|
